ID   HC-7-5/VCR
AC   CVCL_X216
DR   Wikidata; Q54881472
RX   PubMed=2568984;
RX   PubMed=2914273;
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X215 ! HC-7-5
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 8
//
RX   PubMed=2568984; DOI=10.1111/j.1349-7006.1989.tb02339.x; PMCID=PMC5917755;
RA   Asoh, Kuni-ichi
RA   Saburi, Yoshio
RA   Sato, Shin-ichi
RA   Nogae, Ichiro
RA   Kohno, Kimitoshi
RA   Kuwano, Michihiko
RT   "Potentiation of some anticancer agents by dipyridamole against
RT   drug-sensitive and drug-resistant cancer cell lines.";
RL   Jpn. J. Cancer Res. 80:475-481(1989).
//
RX   PubMed=2914273; DOI=10.1002/1097-0142(19890215)63:4<675::AID-CNCR2820630414>3.0.CO;2-I;
RA   Komiyama, Sohtaro
RA   Matsui, Katsuko
RA   Kudoh, Shohji
RA   Nogae, Ichiro
RA   Kuratomi, Yuichiro
RA   Saburi, Yoshio
RA   Asoh, Kuni-ichi
RA   Kohno, Kimitoshi
RA   Kuwano, Michihiko
RT   "Establishment of tumor cell lines from a patient with head and neck
RT   cancer and their different sensitivities to anti-cancer agents.";
RL   Cancer 63:675-681(1989).
//